Bill Text: TX HB3482 | 2019-2020 | 86th Legislature | Introduced


Bill Title: Relating to the designation of centers of excellence for the early diagnosis and treatment of placental disorders.

Spectrum: Partisan Bill (Republican 1-0)

Status: (Introduced) 2019-03-18 - Referred to Public Health [HB3482 Detail]

Download: Texas-2019-HB3482-Introduced.html
  86R7807 JG-D
 
  By: Davis of Harris H.B. No. 3482
 
 
 
A BILL TO BE ENTITLED
 
AN ACT
  relating to the designation of centers of excellence for the early
  diagnosis and treatment of placental disorders.
         BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
         SECTION 1.  Chapter 32, Health and Safety Code, is amended by
  adding Subchapter E to read as follows:
  SUBCHAPTER E. CENTERS OF EXCELLENCE FOR EARLY DIAGNOSIS AND
  TREATMENT OF PLACENTAL DISORDERS
         Sec. 32.101.  DEFINITION. In this subchapter, "placental
  disorder" includes placenta accreta, placenta increta, and
  placenta percreta.
         Sec. 32.102.  DESIGNATION OF CENTERS OF EXCELLENCE. (a) The
  department, in consultation with the maternal mortality and
  morbidity task force established under Chapter 34, shall designate
  as centers of excellence for the early diagnosis and treatment of
  placental disorders one or more health care entities or programs in
  this state, including institutions of higher education or programs
  of those institutions.
         (b)  The executive commissioner, in consultation with the
  department and the maternal mortality and morbidity task force,
  shall adopt rules necessary for a health care entity or program in
  this state to be designated as a center of excellence for early
  diagnosis and treatment of placental disorders.
         Sec. 32.103.  SUBCOMMITTEE. (a) The department, in
  consultation with the maternal mortality and morbidity task force,
  shall appoint a subcommittee of the task force to advise the
  executive commissioner on the adoption of rules under Section
  32.102. As part of the subcommittee's duties under this
  subsection, the subcommittee specifically shall advise the
  executive commissioner on the criteria necessary for a health care
  entity or program in this state to receive a designation under this
  subchapter.
         (b)  The subcommittee must consist of individuals with
  expertise in the early diagnosis and treatment of placental
  disorders. A majority of the members of the subcommittee must
  practice in those areas in a health profession in this state. The
  subcommittee may include national and international experts.
         Sec. 32.104.  PRIORITY CONSIDERATIONS FOR CENTER
  DESIGNATIONS.  The rules adopted under Section 32.102 must
  prioritize awarding a designation under this subchapter to a health
  care entity or program that:
               (1)  offers early diagnosis and treatment services for
  placental disorders through a multi-specialty clinical program
  that is affiliated and collaborates extensively with a medical
  school in this state and an associated hospital that provides
  advanced maternal and neonatal care in accordance with the
  hospital's level of care designation received under Section
  241.182;
               (2)  demonstrates a significant commitment to research
  in and advancing the field of placental disorder care;
               (3)  offers advanced training programs in the early
  diagnosis and treatment of placental disorders; and
               (4)  integrates an advanced placental disorder care
  program with a program that provides appropriate long-term
  monitoring and follow-up care for patients.
         Sec. 32.105.  REQUIREMENTS FOR DESIGNATION. The rules
  adopted under Section 32.102 must ensure that a health care entity
  or program in this state that receives a center of excellence
  designation under this subchapter:
               (1)  provides or is affiliated with a hospital that
  provides advanced maternal and neonatal care in accordance with the
  hospital's level of care designation received under Section
  241.182;
               (2)  implements and maintains a multidisciplinary
  health care team, including maternal fetal medicine specialists,
  pediatric and surgical specialists, neonatologists, nurses with
  specialized maternal and neonatal training, and other ancillary and
  support staff as appropriate to provide care related to placental
  disorders;
               (3)  establishes minimum criteria for medical staff,
  nursing staff, and ancillary and support staff;
               (4)  measures short-term and long-term patient
  diagnostic and therapeutic outcomes; and
               (5)  provides to the department annual reports
  containing aggregate data on short-term and long-term diagnostic
  and therapeutic outcomes as requested or required by the department
  and makes those reports available to the public on the entity's or
  program's Internet website.
         SECTION 2.  (a)  Not later than December 1, 2019, the
  Department of State Health Services, in consultation with the
  maternal mortality and morbidity task force established under
  Chapter 34, Health and Safety Code, shall appoint members to the
  subcommittee as required by Section 32.103, Health and Safety Code,
  as added by this Act.
         (b)  Not later than December 1, 2020, the executive
  commissioner of the Health and Human Services Commission shall
  adopt rules as required by Section 32.102, Health and Safety Code,
  as added by this Act.
         (c)  Not later than September 1, 2021, the Department of
  State Health Services shall begin awarding designations of centers
  of excellence as required by Subchapter E, Chapter 32, Health and
  Safety Code, as added by this Act.
         SECTION 3.  This Act takes effect September 1, 2019.
feedback